List of cell therapy patents

Patents where

Current Assignee

Industry

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 10071148 Immunotherapy against several tumors, such as lung cancer, including NSCLC	Patent 10071148 was granted and assigned to Immatics Biotechnologies on September, 2018 by the United States Patent and Trademark Office.		Immatics Biotechnologies	United States Patent and Trademark Office	10071148	September 11, 2018
‌ US Patent 7316923 Compositions and methods for non-targeted activation of endogenous genes	Patent 7316923 was granted and assigned to Athersys on January, 2008 by the United States Patent and Trademark Office.		Athersys	United States Patent and Trademark Office	7316923	January 8, 2008
‌ US Patent 7048775 Device and method for monitoring the integrity of filtering installations	Patent 7048775 was granted and assigned to Sartorius on May, 2006 by the United States Patent and Trademark Office.		Sartorius	United States Patent and Trademark Office	7048775	May 23, 2006
‌ US Patent 9713503 Surgical utility connector	Patent 9713503 was granted and assigned to Novartis on July, 2017 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	9713503	July 25, 2017
‌ US Patent 10485920 Needle unit with a lockable needle shield and an injection device comprising such a needle unit	Patent 10485920 was granted and assigned to Novo Nordisk on November, 2019 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10485920	November 26, 2019
‌ US Patent 11434274 Peptides and combination of peptides for use in immunotherapy against various tumors	Patent 11434274 was granted and assigned to Immatics Biotechnologies on September, 2022 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11434274	September 6, 2022
‌ US Patent 9072587 Surgical variable-angle illuminator	Patent 9072587 was granted and assigned to Novartis on July, 2015 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	9072587	July 7, 2015
‌ US Patent 8147728 Pad transfer printing of silicone hydrogel lenses using colored ink	Patent 8147728 was granted and assigned to Novartis on April, 2012 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	8147728	April 3, 2012
‌ US Patent 10005827 Double-acylated GLP-1 derivatives	Patent 10005827 was granted and assigned to Novo Nordisk on June, 2018 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10005827	June 26, 2018
‌ US Patent 11421248 Temperature-based transient delivery of nucleic acids and proteins to cells and tissues	Patent 11421248 was granted and assigned to Elixirgen Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Elixirgen Therapeutics	Elixirgen Therapeutics	United States Patent and Trademark Office	11421248	August 23, 2022
‌ US Patent 9315774 Device for the aseptic expansion of cells	Patent 9315774 was granted and assigned to Kuur Therapeutics on April, 2016 by the United States Patent and Trademark Office.	Kuur Therapeutics	Kuur Therapeutics	United States Patent and Trademark Office	9315774	April 19, 2016
‌ US Patent 10335464 Device for titrating basal insulin	Patent 10335464 was granted and assigned to Novo Nordisk on July, 2019 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	10335464	July 2, 2019
‌ US Patent 7500959 Medication delivery system with improved dose accuracy	Patent 7500959 was granted and assigned to Novo Nordisk on March, 2009 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	7500959	March 10, 2009
‌ US Patent 8361036 Injection device having a gearing arrangement	Patent 8361036 was granted and assigned to Novo Nordisk on January, 2013 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	8361036	January 29, 2013
‌ US Patent 7209075 Mobile object locator	Patent 7209075 was granted and assigned to Pfizer on April, 2007 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7209075	April 24, 2007
‌ US Patent 7531511 Method for inducing angiogenesis or vascular perfusion in the myocardium comprising administering FGF-2	Patent 7531511 was granted and assigned to Novartis on May, 2009 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	7531511	May 12, 2009
‌ US Patent 7030242 Selective inhibition of aggrecanase in osteoarthritis treatment	Patent 7030242 was granted and assigned to Pfizer on April, 2006 by the United States Patent and Trademark Office.		Pfizer	United States Patent and Trademark Office	7030242	April 18, 2006
‌ US Patent 7468390 Methods of treatment and pharmaceutical composition	Patent 7468390 was granted and assigned to Novartis on December, 2008 by the United States Patent and Trademark Office.		Novartis	United States Patent and Trademark Office	7468390	December 23, 2008
‌ US Patent 8298172 Medical skin mountable device and system	Patent 8298172 was granted and assigned to Novo Nordisk on October, 2012 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	8298172	October 30, 2012
‌ US Patent 9844321 Enhanced ophthalmic surgical experience using a virtual reality head-mounted display	Patent 9844321 was granted and assigned to Novartis on December, 2017 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	9844321	December 19, 2017
‌ US Patent 7922096 Support for a cartridge for transferring an electronically readable item of information from the cartridge to an electronic circuit	Patent 7922096 was granted and assigned to Novo Nordisk on April, 2011 by the United States Patent and Trademark Office.		Novo Nordisk	United States Patent and Trademark Office	7922096	April 12, 2011
‌ US Patent 9527900 Double-acylated GLP-1 derivatives	Patent 9527900 was granted and assigned to Novo Nordisk on December, 2016 by the United States Patent and Trademark Office.	Novo Nordisk	Novo Nordisk	United States Patent and Trademark Office	9527900	December 27, 2016
‌ US Patent 10016248 Ophthalmic illumination profiles and associated devices, systems, and methods	Patent 10016248 was granted and assigned to Novartis on July, 2018 by the United States Patent and Trademark Office.	Novartis	Novartis	United States Patent and Trademark Office	10016248	July 10, 2018
‌ US Patent 11918605 Chimeric antigen receptor dendritic cell (CAR-DC) for treatment of cancer	Patent 11918605 was granted and assigned to Myeloid Therapeutics on March, 2024 by the United States Patent and Trademark Office.	Myeloid Therapeutics	Myeloid Therapeutics	United States Patent and Trademark Office	11918605	March 5, 2024
‌ US Patent 11559550 Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers	Patent 11559550 was granted and assigned to Immatics Biotechnologies on January, 2023 by the United States Patent and Trademark Office.	Immatics Biotechnologies	Immatics Biotechnologies	United States Patent and Trademark Office	11559550	January 24, 2023

...

Results per page:

6,516 results

0 selected

6,516 results

0 selected